La lunga marcia dei vaccini contro l'HIV
Il
trial testò un regime che prevedeva il vaccino vettore ricombinante ALVAC-HIV
di Sanofi più due iniezioni di richiamo del vaccino ricombinante a ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.